NIPPV (nasal intermittent positive pressure ventilation) and CPAP (continuous positive airway pressure) are the two main forms of non-invasive breathing support used in neonatal intensive care, and the evidence comparing them is more nuanced than a simple winner-loser framing suggests. Across multiple Cochrane reviews and randomized trials, NIPPV generally reduces the risk of respiratory failure and intubation compared to CPAP when used early, but the advantage narrows or disappears in certain populations, with specific delivery devices, and over longer time horizons. Choosing between them involves trade-offs that shift depending on the clinical scenario, the infant’s gestational age, and the equipment available.
What Each Mode Actually Does
CPAP delivers a constant stream of pressurized air through the nose, keeping the airways open by maintaining a steady baseline pressure throughout the breathing cycle. The infant breathes on their own against that continuous cushion of pressure, which prevents the tiny air sacs in the lungs from collapsing between breaths. NIPPV adds intermittent bursts of higher pressure on top of that same baseline. In practice, the ventilator cycles between a lower pressure (similar to CPAP) and a higher peak pressure, mimicking the rhythm of a breath but delivered non-invasively through nasal prongs or a mask.
The additional pressure peaks in NIPPV help clear carbon dioxide even when only a small fraction of a normal breath volume reaches the lungs. Research using bench lung models has shown that COâ‚‚ elimination during NIPPV is directly proportional to the inspiratory pressure, and that it works even when a substantial portion of the set pressure is lost before reaching the lungs. Interestingly, one study found that the type of nasal interface matters: short binasal prongs transmitted roughly 12% of the set pressure to the lungs, while RAM cannulae transmitted only about 3%, resulting in significantly less COâ‚‚ clearance with the latter device.
1Journal of Perinatology. Neonatal nasal intermittent positive pressure ventilation efficacy and lung pressure transmissionEarly Respiratory Support After Birth
When a preterm infant is born with respiratory distress syndrome, clinicians face an immediate decision about which form of non-invasive support to start. The largest body of evidence here favors NIPPV. A Cochrane review pooling 17 randomized trials and nearly 2,000 infants found that NIPPV started within six hours of birth likely reduces respiratory failure by about 35% and cuts the need for intubation by roughly a third compared to CPAP alone.
2PubMed Central. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infantsA 2026 randomized trial reinforced that pattern. Among preterm infants with respiratory distress syndrome, non-invasive ventilation failure within the first 72 hours occurred in about 26% of the CPAP group versus 13% of the NIPPV group, a statistically significant gap. The researchers calculated a nearly 99% probability that the difference was not due to chance.
3JAMA Network Open. Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation in Preterm Infants With Respiratory Distress Syndrome: A Randomized Clinical TrialA smaller trial in Iran found a similar pattern: intubation within the first 72 hours was needed in about 18% of CPAP-treated infants versus 6% of those on NIPPV.
4PubMed Central. Comparison of Complications and Efficacy of NIPPV and Nasal CPAP in Preterm Infants With RDSThere is an important caveat here. Most of these trials enrolled infants born at roughly 28 to 32 weeks’ gestation, with average gestational ages around 30 weeks. The Cochrane reviewers were clear that the findings may not apply to the most extremely preterm infants, those born before 28 weeks, who are at the highest risk of needing mechanical ventilation in the first place.
5Cochrane Database of Systematic Reviews. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infantsAfter Extubation
The other major use case is supporting a baby who has just been taken off a mechanical ventilator. Keeping these infants breathing successfully without re-intubation is a central challenge in the NICU. A Cochrane review of 19 trials and over 2,700 infants found that NIPPV likely reduces post-extubation respiratory failure, with a risk ratio of 0.75. Roughly 11 infants need to be treated with NIPPV instead of CPAP to prevent one case of respiratory failure. The risk of re-intubation was also lower, and there were fewer pulmonary air leaks.
6PubMed Central. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubationBut this advantage is not universal. A randomized trial focused specifically on very low birth weight infants using non-synchronized NIPPV found essentially identical extubation failure rates: about 32% in both the CPAP and NIPPV groups. The difference between this trial and the broader Cochrane finding likely comes down to the population studied and the mode of NIPPV delivery, a distinction that turns out to matter quite a lot.
7Neonatology. Randomized Controlled Trial of Nonsynchronized Nasal Intermittent Positive Pressure Ventilation versus Nasal CPAP after Extubation of VLBW InfantsDoes Synchronization Make a Difference?
NIPPV can be delivered in two ways: synchronized, where the ventilator times its pressure peaks to coincide with the baby’s own breath attempts, and non-synchronized, where the peaks fire at preset intervals regardless of what the infant is doing. In theory, synchronization should be more effective because the extra pressure arrives exactly when the baby is inhaling, augmenting each breath rather than occasionally fighting against it. Non-synchronized NIPPV inevitably produces some “wasted” pressure peaks that land during exhalation or at other unhelpful moments.
The evidence on whether this theoretical advantage translates into better outcomes is mixed and surprisingly thin. One study using a SiPAP device found that while its synchronization system triggered rapidly with most spontaneous breaths, the synchronized pressure peaks did not actually produce larger tidal volumes, and pressure peaks delivered during apnea generated no volume at all.
8Archives of Disease in Childhood – Fetal and Neonatal Edition. Effects of synchronisation during SiPAP-generated nasal intermittent positive pressure ventilation (NIPPV) in preterm infantsA pilot feasibility study tested synchronized NIPPV as the very first respiratory support after birth in very preterm infants and found that reasonable synchrony could be achieved even in the chaotic environment of post-delivery stabilization, where babies are frequently stimulated and handled. But it was a small pilot, and the researchers stressed the need for larger trials before drawing conclusions about clinical benefit.
9PubMed. Synchronised Non-Invasive Intermittent Positive Pressure Ventilation in Very Preterm Infants After Birth: A Feasibility StudyThe post-extubation trial that showed identical failure rates between CPAP and NIPPV used non-synchronized NIPPV specifically. This has led many clinicians to suspect that the pooled benefits of NIPPV seen in Cochrane reviews may be driven disproportionately by trials that used synchronized delivery. Unfortunately, most available ventilators in many NICUs do not offer a reliable synchronization mode for non-invasive ventilation, which limits how applicable the best-case evidence is in practice.
Work of Breathing
One straightforward question clinicians ask is whether NIPPV actually makes it easier for the baby to breathe. The answer depends on how you deliver it. A study measuring work of breathing in premature infants with respiratory distress syndrome found that synchronized NIPPV significantly reduced inspiratory work of breathing compared to CPAP at the same baseline pressure.
10PubMed. Synchronized nasal intermittent positive pressure ventilation (SNIPPV) decreases work of breathing (WOB) in premature infants with respiratory distress syndrome (RDS) compared to nasal continuous positive airway pressure (NCPAP)However, a crossover study comparing NIPPV to high CPAP (where the baseline CPAP pressure was raised to match the mean airway pressure of NIPPV) found no significant differences in diaphragm electrical activity or work of breathing indices between the two modes. Peak diaphragm signals were similar, and so were the minimum signals during exhalation.
11PubMed Central. High CPAP vs. NIPPV in preterm neonates — A physiological cross-over studyThis is a telling finding. It suggests that some of the benefit attributed to NIPPV may simply come from higher average airway pressure, which CPAP can also provide if the clinician dials it up. The intermittent pressure peaks in NIPPV raise the mean pressure above the set baseline, so a fair comparison needs to match that mean, not just the baseline. When researchers did exactly that, the two modes looked equivalent in terms of how hard the baby’s diaphragm had to work.
Apnea of Prematurity
Apnea, the brief pauses in breathing common in preterm infants, is another scenario where NIPPV is sometimes preferred. The logic is intuitive: if a baby stops breathing, a machine that periodically pushes air in might restart the effort better than one that just holds the airway open passively. The evidence here is genuinely equivocal. A systematic review and meta-analysis of eight studies with over 450 patients found no difference in the hourly rate of apnea episodes between NIPPV and CPAP. However, a secondary analysis across 10 studies and 872 patients found that infants on NIPPV were about half as likely to experience any apnea events at all.
12PubMed. Nasal Intermittent Positive Pressure Ventilation versus Continuous Positive Airway Pressure and Apnea of Prematurity: A Systematic Review and Meta-AnalysisThe older Cochrane review on this specific question included only two very small trials and found conflicting results: one showed no significant difference, while the other favored NIPPV. The reviewers concluded there was insufficient evidence to recommend one over the other for apnea management specifically.
13Cochrane Database of Systematic Reviews. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurityIn practice, many NICUs still start with CPAP for isolated apnea and escalate to NIPPV if apnea persists, a pragmatic approach that reflects the uncertain evidence base rather than any clear guideline.
Does NIPPV Cause Air Leaks or Other Lung Injury?
A reasonable worry about pushing more pressure into a premature infant’s lungs is that it might cause air leaks, where air escapes from the lungs into the surrounding chest cavity. The Cochrane review on early NIPPV found no meaningful difference in pneumothorax rates between NIPPV and CPAP. The post-extubation Cochrane review actually found NIPPV may reduce air leaks compared to CPAP, though the evidence was low certainty.
6PubMed Central. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubationThe early NIPPV Cochrane review found little to no difference in pneumothorax rates across 16 trials, nor in rates of severe brain bleeding.
14Cochrane Database of Systematic Reviews. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infantsSo at least in the short term, NIPPV does not appear to be more dangerous than CPAP in terms of acute lung complications. The higher peak pressures are substantially dampened by the time they reach the infant’s lungs through nasal interfaces, which provides a natural safety margin that invasive ventilation does not have.
Longer-Term Lung Outcomes and Bronchopulmonary Dysplasia
The Cochrane data on early NIPPV showed it may slightly reduce chronic lung disease, also known as bronchopulmonary dysplasia (BPD), compared to CPAP. But this is where the picture gets more complicated. A retrospective study of extremely low birth weight infants found that those who received prolonged NIPPV actually had higher rates of moderate to severe BPD compared to infants on CPAP: about 84% versus 66%. Each additional day on NIPPV was associated with an 8% increase in the odds of developing moderate to severe BPD, and each additional week increased those odds by about 5% after adjusting for total time on oxygen and other respiratory support.
15PubMed. Prolonged non-invasive ventilation in extremely low birth weight preterm infants is associated with bronchopulmonary dysplasiaThis study cannot prove that NIPPV caused the extra lung disease. It is possible, even likely, that the sickest infants were placed on NIPPV precisely because they were already on a trajectory toward worse lung outcomes. But the association is a reminder that non-invasive does not mean harmless when used for extended periods, and it raises questions about whether there is a point at which clinicians should be trying harder to wean infants off NIPPV rather than leaving them on it indefinitely.
Nasal Trauma
Both CPAP and NIPPV are delivered through nasal interfaces, prongs that sit inside the nostrils or masks that cover the nose, and both cause nasal injuries at disturbingly high rates. One incidence study of infants on nasal CPAP found that over 90% developed some degree of nasal pressure injury, with about 11% experiencing severe injuries.
16Journal of Neonatal Nursing. Nasal pressure injuries among newborns caused by nasal CPAP: An incidence studyA retrospective study at a single center found that NIPPV was the most common ventilation mode at the time of nasal trauma, accounting for about 79% of cases. Adhesions were the most common type of injury, and the median time from starting CPAP or NIPPV to developing trauma was 15 days.
17PubMed Central. Nasal Trauma Among Neonatal Intensive Care Unit Patients: A Retrospective Single Center ExperienceOne strategy that has shown promise is rotating between different interface types. A randomized trial comparing systematic rotation of nasal masks and prongs against continuous use of either device alone found that rotation significantly reduced nasal injury compared to continuous prongs, without increasing treatment failure rates.
18PubMed Central. Systematic rotation versus continuous application of ‘nasal prongs’ or ‘nasal mask’ in preterm infants on nCPAP: a randomized controlled trialNasal trauma is one of those complications that rarely makes headlines but substantially affects day-to-day care. Nurses spend considerable time repositioning interfaces, monitoring skin integrity, and managing injuries that can become infected or cause lasting cosmetic changes. Whether NIPPV causes more nasal trauma than CPAP specifically because of the higher pressures is unclear; the retrospective data showing NIPPV predominating may simply reflect that sicker babies who are on NIPPV tend to stay on non-invasive support longer.
Hemodynamic Effects
Parents and clinicians sometimes worry that pushing air pressure into a tiny baby’s chest might affect blood flow to the brain or heart. A study comparing the hemodynamic effects of NIPPV and CPAP in stable preterm infants found no significant differences in cardiac output from either side of the heart, blood flow through the major vein returning blood from the brain, or blood flow velocity in the brain’s main artery.
19PubMed Central. Hemodynamic Effects of Nasal Intermittent Positive Pressure Ventilation in Preterm InfantsThis is reassuring, though it reflects stable infants rather than the sickest babies on the highest settings. In extremely fragile infants with compromised circulation, clinicians still monitor hemodynamics closely when escalating support.
Cost and Equipment Considerations
NIPPV requires a ventilator capable of cycling between two pressure levels, which is generally more expensive than a standalone CPAP device. The cost difference matters in both well-resourced and resource-limited settings. A prospective economic evaluation alongside a large non-invasive ventilation trial found that hospitalization costs were statistically similar between NIPPV and CPAP, roughly $144,000 versus $140,000 per infant. But the analysis concluded there was a 61% probability that NIPPV was both more expensive and less effective than CPAP as employed in that trial, making it economically unfavorable.
20Journal of Perinatology. Prospective economic evaluation alongside the non-invasive ventilation trialA study from a tertiary NICU in India found that standalone bubble CPAP was equally effective as non-synchronized ventilator-delivered NIPPV for preventing extubation failure in preterm neonates, without increasing hospital stay or other adverse outcomes.
21GAIMS Journal of Medical Sciences. A Retrospective Cohort Study to Compare the Efficacy of Continuous Positive Airway Pressure and Non-Synchronised Nasal Intermittent Positive Pressure Ventilation as Primary Post Extubation Respiratory Support in Preterm Neonates Admitted for Severe Respiratory Distress Syndrome in a Tertiary Care NICUThis finding has real implications for NICUs in lower-resource settings, where bubble CPAP systems can be assembled at a fraction of the cost of a mechanical ventilator. If non-synchronized NIPPV does not clearly outperform CPAP, the economic argument for investing in ventilators primarily for NIPPV capability weakens. The benefits of synchronized NIPPV may still justify the expense, but most lower-cost ventilators do not offer reliable synchronization for non-invasive modes.
Weaning Off Non-Invasive Support
Eventually, the goal is to get the infant breathing independently, and how you wean from respiratory support matters. A systematic review of weaning strategies from CPAP found that stepping down to a low-flow nasal cannula allowed infants to come off support almost three weeks earlier in terms of corrected gestational age. The trade-off was that these infants spent about eight extra days on supplemental oxygen compared to those weaned directly off CPAP.
22BMJ. Weaning strategies for the withdrawal of non-invasive respiratory support applying continuous positive airway pressure in preterm infants: a systematic review and meta-analysisLess is known specifically about weaning from NIPPV. In practice, many units step down from NIPPV to CPAP as the infant improves, using CPAP as an intermediate stage before transitioning to nasal cannula or room air. There are no large randomized trials directly comparing NIPPV-to-CPAP-to-off versus NIPPV-straight-to-off, so weaning protocols remain largely institutional preference. Given the observational data linking prolonged NIPPV to worse lung outcomes, though, the clinical instinct to step down to CPAP as soon as the baby tolerates it seems reasonable even without trial-level evidence to confirm it.